Valuation : EDAP TMS S.A.

Market Cap 193M 166M 157M 143M 267M 18.4B 268M 1.85B 717M 9.38B 726M 711M 29.7B P/E 2026 *
-3.53x
P/E 2027 * -5.47x
Enterprise Value 193M 166M 157M 143M 267M 18.4B 268M 1.85B 717M 9.38B 726M 711M 29.7B EV / Sales 2026 *
3.72x
EV / Sales 2027 * 2.77x
Free-Float
32.85%
Yield 2026 *
-
Yield 2027 * -
1 day-0.24%
1 week-2.55%
Current month-1.64%
1 month-32.48%
3 months-8.70%
6 months+1.69%
Current year+27.66%
1 week 4.11
Extreme 4.11
4.4
1 month 4.01
Extreme 4.01
6.28
Current year 3.1
Extreme 3.1
6.4
1 year 1.75
Extreme 1.75
6.4
3 years 1.21
Extreme 1.21
8.5
5 years 1.21
Extreme 1.21
12.65
10 years 1.21
Extreme 1.21
12.65
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2023
Director of Finance/CFO 55 01/01/2024
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 64 01/08/2023
Chairman 64 01/09/2024
Director/Board Member 62 08/07/2024
Date Insider Type Main position Quantity % Market Cap. Importance
14/08/26 Buy

Chief Financial Officer

5,000 0.0133%
14/08/26 Buy

Director

10,000 0.0267%
14/08/26 Buy

Chairman

50,000 0.1334%
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%-2.55%+53.28%-32.91% 193M
+0.44%+0.86%+24.21%+16.87% 223B
-0.19%-1.01%+3.13%-17.52% 144B
+0.88%-4.34%-24.84%+18.45% 124B
-0.04%-6.49%-58.42%-16.54% 65.19B
-0.62%-5.03%+7.44%+16.35% 49.99B
-0.79%-1.55%-18.62%-13.39% 50.49B
-1.43%-3.45%+12.97%+26.98% 41.4B
+0.47%-0.25%+30.85%+53.59% 39.59B
-2.87%-1.03%+108.80%+29.45% 31.87B
Average -0.44%-2.11%+13.88%+8.13% 76.97B
Weighted average by Cap. -0.03%-1.80%+4.72%+8.77%

Financials

2026 *2027 *
Net sales 52M 44.69M 42.08M 38.39M 71.74M 4.95B 72.07M 498M 193M 2.52B 195M 191M 7.98B 69.73M 59.93M 56.43M 51.48M 96.21M 6.63B 96.65M 668M 258M 3.38B 262M 256M 10.71B
Net income -47.66M -40.96M -38.57M -35.19M -65.76M -4.53B -66.06M -457M -177M -2.31B -179M -175M -7.32B -31.59M -27.15M -25.56M -23.32M -43.58M -3B -43.78M -303M -117M -1.53B -119M -116M -4.85B
Net Debt - -
Logo EDAP TMS S.A.
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Employees
289
Date Price Change Volume
09/09/26 $4.200 -0.24% 87,400
08/09/26 $4.210 +1.45% 109,693
04/09/26 $4.150 -0.48% 103,139
03/09/26 $4.170 -1.18% 32,069
02/09/26 $4.220 -2.09% 112,976
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.210USD
Average target price
8.600USD
Spread / Average Target
+104.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FOCL Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!